Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision indicator updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-07T20:20:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2, which appears to be a backend/version label with no visible impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:58:49.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T22:52:18.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The updates add UI elements to show/hide the glossary and adjust the page's metadata in the footer, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-23T17:24:14.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T11:06:44.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page's Locations section was updated to include a new consolidated Locations heading with entries for New South Wales, Perth, Queensland, and Victoria, while the separate region-specific location entries were removed and the revision tag updated to v3.3.3. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-18T21:41:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.